Scott M. Lippman, M.D.: Short CV
Scott M. Lippman, M.D.: Short CV
Scott M. Lippman, M.D.: Short CV
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Curriculum Vitae<br />
<strong>Scott</strong> M. <strong>Lippman</strong>, M.D.<br />
Page 24<br />
184. Wu X, <strong>Lippman</strong> SM, Lee JJ, Zhu Y, Wei QV, Thomas M, Hong WK, Spitz MR.<br />
Chromosome instability in lymphocytes: a potential indicator of predisposition to<br />
oral premalignant lesions. Cancer Res 62:2813-8, 2002.<br />
185. Shureiqi I, Cantor SB, <strong>Lippman</strong> SM, Brenner DE, Chernew ME, Fendrick AM.<br />
Clinical and economic impact of multiple gated acquisition scan monitoring<br />
during anthracycline therapy. Br J Cancer 86:226-32, 2002.<br />
186. O’Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian<br />
CJ, Sigman CC, Bertagnolli MM, Stratton SP, Lam S, Nelson WG, Meyskens FL,<br />
Alberts DS, Follen M, Rustgi AK, Papadimitrakopoulou V, Scardino PT, Gazdar<br />
AF, Wattenberg LW, Sporn MB, Sakr WA, <strong>Lippman</strong> SM, Von Hoff DD.<br />
Treatment and prevention of intraepithelial neoplasia: an important target for<br />
accelerated new agent development. Clin Cancer Res 8:314-46, 2002.<br />
187. <strong>Lippman</strong> SM, Hong WK. Cancer prevention by delay. Clin Cancer Res 8:305-<br />
13, 2002.<br />
188. Li M, Song S, <strong>Lippman</strong> SM, Zhang XK, Liu X, Lotan R, Xu XC. Induction of<br />
retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal<br />
cancer cells. Oncogene 21:411-18, 2002.<br />
189. Shin DM, Glisson BS, Khuri FR, Clifford JL, Clayman G, Benner SE, Forastiere<br />
AA, Ginsberg L, Liu D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK,<br />
<strong>Lippman</strong> SM. Phase II and biologic study of interferon alfa, retinoic acid, and<br />
cisplatin in advanced squamous skin cancer. J Clin Oncol 20:364-70, 2002.<br />
190. Shureiqi I, Jiang W, Fischer SM, Xu X, Chen D, Lee JJ, Lotan R, <strong>Lippman</strong> SM.<br />
GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced<br />
apoptosis in colorectal cancer cells. Cancer Res 62:1178-83, 2002.<br />
191. <strong>Lippman</strong> SM, Hong WK. Cancer prevention science and practice. Cancer Res<br />
62:5119-25, 2002.<br />
192. Sabichi AL, Modiano MR, Lee JJ, Peng YM, Xu MJ, Villar H, Dalton WS,<br />
<strong>Lippman</strong> SM. Breast tissue accumulation of retinamides in a randomized shortterm<br />
study of fenretinide. Clin Cancer Res 9:2400-5, 2003.<br />
193. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber<br />
MM, Cespedes RD, Atkins JN, <strong>Lippman</strong> SM, Carlin SM, Ryan A, Szczepanek<br />
CM, Crowley JJ, Coltman CA Jr. The influence of finasteride on the<br />
development of prostate cancer. N Engl J Med 349:215-24, 2003.<br />
194. Clifford JL, Yang X, Walch E, Wang M, <strong>Lippman</strong> SM. Dominant negative<br />
signal transducer and activator of transcription 2 (STAT2) protein: stable<br />
expression blocks interferon alpha action in skin squamous cell carcinoma cells.<br />
Mol Cancer Ther 2:453-9, 2003.<br />
195. Liang Z, <strong>Lippman</strong> SM, Kawabe A, Shimada Y, Xu XC. Identification of<br />
benzo(a)pyrene diol epoxide-binding DNA fragments using DNA<br />
immunoprecipation technique. Cancer Res 63:1470-4, 2003.<br />
196. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang<br />
DG, <strong>Lippman</strong> SM. Reduced 15S-lipoxygenase-2 expression in esophageal<br />
cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2<br />
inhibitor, NS398. Neoplasia 5:121-7, 2003.